Skip to main content
Erschienen in: Herz 1/2021

22.01.2020 | Original articles

Effects of grapeseed extract on doxorubicin-induced cardiotoxicity in rats

verfasst von: Mehmet Şahin Adıyaman, Özlem Aba Adıyaman, Adile Ferda Dağlı, Mehmet Zülkif Karahan, İlyas Kaya, Mustafa Necati Dağlı

Erschienen in: Herz | Sonderheft 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Doxorubicin (DX) is used for the treatment of many types of cancer; however, a side effect of this agent is cardiotoxicity, which may lead to cardiomyopathy or cardiac failure. Oxidative stress is thought to play a major role in the development of cardiotoxic effects. Proanthocyanidins found in grapeseed (GS) extract may inhibit chemically induced lipid peroxidation and apoptosis caused by oxidative stress. We aimed to investigate the cardioprotective effects of GS extract against DX-induced cardiotoxicity.

Methods

A total of 28 male Sprague Dawley rats were grouped to receive: (a) standard nutrition (n = 7); (b) standard nutrition with an additional dose of 10 mg/kg DX (n = 7); (c) standard nutrition plus 100 mg/kg/day of GS (n = 7); (d) standard nutrition with 100 mg/kg/day of GS plus a single dose of 10 mg/kg DX. After 35 days the rats were decapitated and blood samples were taken for biochemical testing. Cardiac tissue samples were prepared for microscopy and histopathological evaluation.

Results

Rats in the DX group exhibited significant elevations in biomarkers such as troponin and NT-proBNP as well as in oxidative stress markers compared with all other groups. Histopathological examination corroborated these findings by demonstrating significant and severe structural injury in the cardiac tissue of DX rates. Moreover, rats in the DX + GS group had significantly lower cardiac injury than rats in the DX group according to both biochemical (troponin and NT-proBNP) and histopathological analyses. Serum malondialdehyde levels (a marker of oxidative stress) in the DX + GS rats were significantly lower than in the DX rats.

Conclusion

Our findings suggest that GS may reduce the severity of DX-induced cardiotoxicity and thus has the potential to prevent cardiac injury in this setting.
Literatur
1.
Zurück zum Zitat Muggia FM, Green MD (1991) New anthracycline antitumor antibiotics. Crit Rev Oncol Hematol 11:43–64CrossRef Muggia FM, Green MD (1991) New anthracycline antitumor antibiotics. Crit Rev Oncol Hematol 11:43–64CrossRef
2.
Zurück zum Zitat Hideg K, Kálai T (2007) Novel antioxidants in anthracycline cardiotoxicity. Cardiovasc Toxicol 7:160–164CrossRef Hideg K, Kálai T (2007) Novel antioxidants in anthracycline cardiotoxicity. Cardiovasc Toxicol 7:160–164CrossRef
3.
Zurück zum Zitat Yeh ET, Tong AT, Lenihan DJ, Yusuf SW, Swafford J, Champion C, Durand JB, Gibbs H, Zafarmand AA, Ewer MS (2004) Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation 109:3122–3131CrossRef Yeh ET, Tong AT, Lenihan DJ, Yusuf SW, Swafford J, Champion C, Durand JB, Gibbs H, Zafarmand AA, Ewer MS (2004) Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation 109:3122–3131CrossRef
4.
Zurück zum Zitat Biner B (2000) Çocukluk Çağı Akut Lösemilerinde Erken ve Geç Dönem Antrasiklin Kardiyotoksisitesinin Tanısında Kardiyak Troponin T ve Ekokardiyografi. Uzmanlık Tezi. İstanbul Üniversitesi İstanbul Tıp Fakültesi, Sağlık Bilimleri Estitüsü, İstanbul Biner B (2000) Çocukluk Çağı Akut Lösemilerinde Erken ve Geç Dönem Antrasiklin Kardiyotoksisitesinin Tanısında Kardiyak Troponin T ve Ekokardiyografi. Uzmanlık Tezi. İstanbul Üniversitesi İstanbul Tıp Fakültesi, Sağlık Bilimleri Estitüsü, İstanbul
5.
Zurück zum Zitat Menna P, Salvatorelli E, Minotti G (2008) Cardiotoxicity of antitumor drugs. Chem Res Toxicol 21:978–989CrossRef Menna P, Salvatorelli E, Minotti G (2008) Cardiotoxicity of antitumor drugs. Chem Res Toxicol 21:978–989CrossRef
6.
Zurück zum Zitat Xin H, Liu XH, Zhu YZ (2009) Herba leonurine attenuates doxorubicin-induced apoptosis in H9c2 cardiac muscle cells. Eur J Pharmacol 612:75–79CrossRef Xin H, Liu XH, Zhu YZ (2009) Herba leonurine attenuates doxorubicin-induced apoptosis in H9c2 cardiac muscle cells. Eur J Pharmacol 612:75–79CrossRef
7.
Zurück zum Zitat Bagchi D, Garg A, Krohn RL (1998) Protective effects of grape seed proanthocyanidins and selected antioxidants against TPA-induced hepatic and brain lipid peroxidation and DNA fragmentation, and peritoneal macrophage activation in mice. Gen Pharmacol 30:771–776CrossRef Bagchi D, Garg A, Krohn RL (1998) Protective effects of grape seed proanthocyanidins and selected antioxidants against TPA-induced hepatic and brain lipid peroxidation and DNA fragmentation, and peritoneal macrophage activation in mice. Gen Pharmacol 30:771–776CrossRef
8.
Zurück zum Zitat Rice-Evans CA, Miller NJ, Paganda G (1996) Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 20:933–956CrossRef Rice-Evans CA, Miller NJ, Paganda G (1996) Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 20:933–956CrossRef
9.
Zurück zum Zitat Esterbauer H, Cheeseman KH (1990) Determination of aldehydic lipid per-oxidation products: malonaldehyde and 4hydroxynonenal. Methods Enzymol 186:407–421CrossRef Esterbauer H, Cheeseman KH (1990) Determination of aldehydic lipid per-oxidation products: malonaldehyde and 4hydroxynonenal. Methods Enzymol 186:407–421CrossRef
10.
Zurück zum Zitat Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103–1111CrossRef Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103–1111CrossRef
11.
Zurück zum Zitat Erel O (2004) A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 37:112–119CrossRef Erel O (2004) A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 37:112–119CrossRef
12.
Zurück zum Zitat Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L (2004) Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56:185–229CrossRef Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L (2004) Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56:185–229CrossRef
13.
Zurück zum Zitat Singal PK, Deally CM, Weinberg LE (1987) Subcellular effects of adriamycin in the heart: a concise review. J Mol Cell Cardiol 19:817–828CrossRef Singal PK, Deally CM, Weinberg LE (1987) Subcellular effects of adriamycin in the heart: a concise review. J Mol Cell Cardiol 19:817–828CrossRef
14.
Zurück zum Zitat Doroshow JH (1983) Anthracycline antibiotic-stimulated superoxide, hydrogen peroxide, and hydroxyl radical production by NADH dehydrogenase. Cancer Res 43:4543–4551PubMed Doroshow JH (1983) Anthracycline antibiotic-stimulated superoxide, hydrogen peroxide, and hydroxyl radical production by NADH dehydrogenase. Cancer Res 43:4543–4551PubMed
15.
Zurück zum Zitat Sardao VA, Oliveira PJ, Holy J, Oliveira CR, Wallace KB (2009) Morphological alterations induced by doxorubicin on H9c2 myoblasts: nuclear, mitochondrial, and cytoskeletal targets. Cell Biol Toxicol 25:227–243CrossRef Sardao VA, Oliveira PJ, Holy J, Oliveira CR, Wallace KB (2009) Morphological alterations induced by doxorubicin on H9c2 myoblasts: nuclear, mitochondrial, and cytoskeletal targets. Cell Biol Toxicol 25:227–243CrossRef
16.
Zurück zum Zitat Zhang XY, Li WG, Wu YJ, Gao MT (2005) Amelioration of doxorubicininduced myocardial oxidative stress and immunosuppression by grape seed proanthocyanidins in tumour-bearing mice. J Pharm Pharmacol 57:1043–1052CrossRef Zhang XY, Li WG, Wu YJ, Gao MT (2005) Amelioration of doxorubicininduced myocardial oxidative stress and immunosuppression by grape seed proanthocyanidins in tumour-bearing mice. J Pharm Pharmacol 57:1043–1052CrossRef
17.
Zurück zum Zitat Du Y, Lou H (2008) Catechin and proanthocyanidin B4 from grape seeds prevent doxorubicininduced toxicity in cardiomyocytes. Eur J Pharmacol 591:96–101CrossRef Du Y, Lou H (2008) Catechin and proanthocyanidin B4 from grape seeds prevent doxorubicininduced toxicity in cardiomyocytes. Eur J Pharmacol 591:96–101CrossRef
18.
Zurück zum Zitat Cetin A, Kaynar L, Kocyigit I, Hacioglu SK, Saraymen R, Ozturk A, Sari I, Sagdic O (2008) Role of grape seed extract on methotrexate induced oxidative stress in rat liver. Am J Chin Med 36:861–872CrossRef Cetin A, Kaynar L, Kocyigit I, Hacioglu SK, Saraymen R, Ozturk A, Sari I, Sagdic O (2008) Role of grape seed extract on methotrexate induced oxidative stress in rat liver. Am J Chin Med 36:861–872CrossRef
19.
Zurück zum Zitat Chang WT, Shao ZH, Yin JJ, Mehendale S, Wang CZ, Qin Y et al (2007) Comparative effects of flavonoids on oxidant scavenging and ischemia-reperfusion injury in cardiomyocytes. Eur J Pharmacol 566:58–66CrossRef Chang WT, Shao ZH, Yin JJ, Mehendale S, Wang CZ, Qin Y et al (2007) Comparative effects of flavonoids on oxidant scavenging and ischemia-reperfusion injury in cardiomyocytes. Eur J Pharmacol 566:58–66CrossRef
20.
Zurück zum Zitat Uchida S, Hirai K, Hatanaka J, Hanato J, Umegaki K, Yamada S (2008) Antinociceptive effects of St. John’s wort, harpagophytum procumbens extract and grape seed proanthocyanidins extract in mice. Biol Pharm Bull 31:240–245CrossRef Uchida S, Hirai K, Hatanaka J, Hanato J, Umegaki K, Yamada S (2008) Antinociceptive effects of St. John’s wort, harpagophytum procumbens extract and grape seed proanthocyanidins extract in mice. Biol Pharm Bull 31:240–245CrossRef
21.
Zurück zum Zitat Ahmed HH, Mannaa F, Elmegeed GA, Doss SH (2005) Cardioprotective activity of melatonin and its novel synthesized derivatives on doxorubicin-induced cardiotoxicity. Bioorg Med Chem 13:1847–1857CrossRef Ahmed HH, Mannaa F, Elmegeed GA, Doss SH (2005) Cardioprotective activity of melatonin and its novel synthesized derivatives on doxorubicin-induced cardiotoxicity. Bioorg Med Chem 13:1847–1857CrossRef
Metadaten
Titel
Effects of grapeseed extract on doxorubicin-induced cardiotoxicity in rats
verfasst von
Mehmet Şahin Adıyaman
Özlem Aba Adıyaman
Adile Ferda Dağlı
Mehmet Zülkif Karahan
İlyas Kaya
Mustafa Necati Dağlı
Publikationsdatum
22.01.2020
Verlag
Springer Medizin
Erschienen in
Herz / Ausgabe Sonderheft 1/2021
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-019-04888-w

Weitere Artikel der Sonderheft 1/2021

Herz 1/2021 Zur Ausgabe

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.